ATAGI recommends a winter COVID-19 booster dose for people at increased risk of severe COVID-19. The additional winter booster is recommended for other people at increased risk, to be given 4 months after their first booster dose or COVID-19 infection (if applicable). adults aged 65 years and older residents 16 years and older of aged
The Therapeutic Goods Administration (TGA) has granted provisional approval to Biocelect Pty Ltd (on behalf of Novavax Inc) for its COVID-19 vaccine, NUVAXOVID for primary vaccination in individuals 18 years of age and older. This is the first protein COVID-19 vaccine to receive regulatory approval in Australia. It is recommended that the vaccine is given
The TGA has announced it has provisionally approved the Pfizer COVID-19 vaccine as a booster dose in individuals aged 18 years and over. The vaccine may be administered 6 months after the second dose of the primary series of any approved COVID-19 vaccine. Additionally, it can be given as a booster dose 28 days after
The Therapeutic Goods Administration (TGA) granted provisional approval to Moderna Australia Pty Ltd for its COVID-19 vaccine in August, with the approval for use in individuals 12 years and older granted on 4th September 2021. The Product Information, FAQs and information on labelling and batch testing are also available on the COVID-19 vaccines hub. Further information
The Australian Commission on Safety and Quality in Health Care (ACSQHC) has published its Fourth Australian report on antimicrobial use and resistance in human health (AURA 2021). The most comprehensive report produced on Australian antimicrobial use and resistance trends to date has found that while antimicrobial use in the community is decreasing, over prescribing and
The content of the Australian Commission on Safety and Quality in Health Care’s Antimicrobial Stewardship in Australian Health Care book continues to grow, with the latest chapter dealing with AMS and community and residential aged care. Key elements include: Aged care services in Australia and infectious diseases and ageing Presentation of infections in older people
On 10 June 2021 the Australian government published new guidance on the use of personal protective equipment (PPE) for health care workers in the context of COVID-19. The National COVID-19 Clinical Evidence Taskforce has now published its full set of consensus guidance on the use of P2/N95 respirators, surgical masks and eye protection. You can
The 2021 ACIPC International Conference will be delivered as a hybrid event with both in-person and online attendance options. The in-person conference will take place at the Adelaide Convention Centre, 7 – 10 November and will include national and international invited speakers, abstract presentations, social events, and a comprehensive trade exhibition. To help facilitate the
The 2021 Preventing and Controlling Infections Standard supersedes the 2017 Preventing and Controlling Healthcare-Associated Infection Standard. The new standard provides further support to health service organisations to prevent, control and respond to infections that cause outbreaks, epidemics or pandemics, including novel and emerging infections. The changes made to the standard clarify existing requirements and reflect the
Mandatory reporting starts today, 15 June 2021, for all approved providers of residential aged care services to report and provide weekly updates every Tuesday on the COVID-19 vaccination status of their aged care workforce. Starting today, 15 June 2021, all approved providers of residential aged care services must report every Tuesday. It will become mandatory